JP2023528204A5 - - Google Patents

Info

Publication number
JP2023528204A5
JP2023528204A5 JP2022568689A JP2022568689A JP2023528204A5 JP 2023528204 A5 JP2023528204 A5 JP 2023528204A5 JP 2022568689 A JP2022568689 A JP 2022568689A JP 2022568689 A JP2022568689 A JP 2022568689A JP 2023528204 A5 JP2023528204 A5 JP 2023528204A5
Authority
JP
Japan
Prior art keywords
recombinant protein
seq
binding domain
fap
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022568689A
Other languages
English (en)
Japanese (ja)
Other versions
JP7843711B2 (ja
JP2023528204A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/062860 external-priority patent/WO2021229067A1/en
Publication of JP2023528204A publication Critical patent/JP2023528204A/ja
Publication of JP2023528204A5 publication Critical patent/JP2023528204A5/ja
Application granted granted Critical
Publication of JP7843711B2 publication Critical patent/JP7843711B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022568689A 2020-05-14 2021-05-14 多選択性タンパク質 Active JP7843711B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP20174847 2020-05-14
EP20174847.2 2020-05-14
EP20181498.5 2020-06-22
EP20181498 2020-06-22
PCT/EP2021/062860 WO2021229067A1 (en) 2020-05-14 2021-05-14 Multispecific proteins

Publications (3)

Publication Number Publication Date
JP2023528204A JP2023528204A (ja) 2023-07-04
JP2023528204A5 true JP2023528204A5 (cg-RX-API-DMAC7.html) 2024-05-09
JP7843711B2 JP7843711B2 (ja) 2026-04-10

Family

ID=75904957

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022568689A Active JP7843711B2 (ja) 2020-05-14 2021-05-14 多選択性タンパク質

Country Status (13)

Country Link
US (2) US20240279290A1 (cg-RX-API-DMAC7.html)
EP (1) EP4149959A1 (cg-RX-API-DMAC7.html)
JP (1) JP7843711B2 (cg-RX-API-DMAC7.html)
KR (1) KR20230022176A (cg-RX-API-DMAC7.html)
CN (1) CN115768786A (cg-RX-API-DMAC7.html)
AU (1) AU2021271129A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022023049A2 (cg-RX-API-DMAC7.html)
CA (1) CA3178785A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022017445A2 (cg-RX-API-DMAC7.html)
IL (1) IL298168A (cg-RX-API-DMAC7.html)
MX (1) MX2022014326A (cg-RX-API-DMAC7.html)
TW (1) TW202208408A (cg-RX-API-DMAC7.html)
WO (1) WO2021229067A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020402581A1 (en) 2019-12-11 2022-06-23 Molecular Partners Ag Designed ankyrin repeat domains with altered surface residues
IL298168A (en) 2020-05-14 2023-01-01 Molecular Partners Ag Multispecific proteins
US11981710B2 (en) 2020-08-18 2024-05-14 Athebio Ag N-terminal capping modules of ankyrin repeat domains
EP3957649A1 (en) 2020-08-18 2022-02-23 Athebio AG Improved n-terminal capping modules of ankyrin repeat domains
WO2022190016A1 (en) 2021-03-09 2022-09-15 Molecular Partners Ag Novel darpin based multi-specific t-cell engagers
EP4387984A1 (en) * 2021-08-17 2024-06-26 Athebio AG Variants of ankyrin repeat domains
WO2023110983A1 (en) * 2021-12-14 2023-06-22 Molecular Partners Ag Designed repeat domains with dual binding specificity and their use
WO2025163082A1 (en) * 2024-01-31 2025-08-07 Molecular Partners Ag Dll3-specific binding constructs and their use in radiotherapy
WO2026150109A1 (en) * 2025-01-10 2026-07-16 Molecular Partners Ag Mesothelin-specific binding constructs and their use in radiotherapy

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
EP1332209B1 (en) 2000-09-08 2009-11-11 Universität Zürich Collections of repeat proteins comprising repeat modules
AR039067A1 (es) 2001-11-09 2005-02-09 Pfizer Prod Inc Anticuerpos para cd40
WO2005063815A2 (en) 2003-11-12 2005-07-14 Biogen Idec Ma Inc. Fcϝ receptor-binding polypeptide variants and methods related thereto
KR20070085314A (ko) 2004-11-12 2007-08-27 바이엘 쉐링 파마 악티엔게젤샤프트 재조합 뉴캐슬 질환 바이러스
KR101268939B1 (ko) 2005-07-08 2013-05-30 유니버시티 오브 취리히 융합 폴리펩티드의 공번역 전좌를 사용한 파아지디스플레이
CA2700391A1 (en) 2007-09-24 2009-04-02 University Of Zuerich Designed armadillo repeat proteins
NZ592591A (en) 2008-11-03 2012-04-27 Molecular Partners Ag Binding proteins comprising ankyrin repeast domains that inhibit the vegf-a receptor interaction
WO2011040972A1 (en) 2009-10-02 2011-04-07 Ludwig Institute For Cancer Research Ltd. Anti-fibroblast activation protein antibodies and methods and uses thereof
TWI510246B (zh) 2010-04-30 2015-12-01 Molecular Partners Ag 抑制vegf-a受體交互作用的經修飾結合性蛋白質
EP3514169B1 (en) 2010-11-26 2024-03-06 Molecular Partners AG Designed repeat proteins binding to serum albumin
WO2012149439A2 (en) 2011-04-29 2012-11-01 Janssen Biotech, Inc. Il4/il13 binding repeat proteins and uses
SG11201408196RA (en) 2012-06-28 2015-03-30 Molecular Partners Ag Designed ankyrin repeat proteins binding to platelet-derived growth factor
EP2906591A1 (en) 2012-10-15 2015-08-19 Universität Zürich Bispecific her2 ligands for cancer therapy
EP2738180A1 (en) 2012-11-30 2014-06-04 Molecular Partners AG Binding proteins comprising at least two binding domains against HER2.
US11453708B2 (en) 2013-05-31 2022-09-27 Molecular Partners Ag Designed ankyrin repeat proteins binding to hepatocyte growth factor
US9458211B1 (en) 2015-04-02 2016-10-04 Molecular Partners Ag Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains
MY196882A (en) 2016-09-22 2023-05-08 Molecular Partners Ag Recombinant binding proteins and their use
CN110402255B (zh) * 2017-04-04 2022-12-02 豪夫迈·罗氏有限公司 新颖的能够特异性结合cd40和fap的双特异性抗原结合分子
AU2018363922B2 (en) 2017-11-08 2025-06-12 Kyowa Kirin Co., Ltd. Bispecific antibody which binds to CD40 and EpCAM
US11242396B2 (en) * 2018-10-01 2022-02-08 Hoffmann-La Roche Inc. Bispecific antigen binding molecules comprising anti-FAP clone 212
KR20220016944A (ko) 2019-06-04 2022-02-10 몰리큘라 파트너스 아게 개선된 안정성을 갖는 설계된 안키린 반복 도메인
JP2022535564A (ja) 2019-06-04 2022-08-09 モレキュラー パートナーズ アクチェンゲゼルシャフト 多選択性タンパク質
CA3139164A1 (en) 2019-06-04 2020-12-10 Molecular Partners Ag Recombinant fap binding proteins and their use
EP3980452A1 (en) 2019-06-04 2022-04-13 Molecular Partners AG Recombinant 4-1bb binding proteins and their use
AU2020402581A1 (en) 2019-12-11 2022-06-23 Molecular Partners Ag Designed ankyrin repeat domains with altered surface residues
CN114945584A (zh) 2019-12-11 2022-08-26 分子合作伙伴股份公司 重组肽-mhc复合物结合蛋白及其生成和用途
MX2022013945A (es) 2020-05-06 2023-02-14 Molecular Partners Ag Nuevas proteinas de union a repeticiones de anquirina y sus usos.
IL298168A (en) 2020-05-14 2023-01-01 Molecular Partners Ag Multispecific proteins
AU2021271131A1 (en) 2020-05-14 2022-12-15 Molecular Partners Ag Recombinant CD40 binding proteins and their use
WO2022101458A1 (en) 2020-11-16 2022-05-19 F. Hoffmann-La Roche Ag Combination therapy with fap-targeted cd40 agonists
AU2021403658A1 (en) 2020-12-16 2023-06-29 Molecular Partners Ag Recombinant cd3 binding proteins and their use
US20240108746A1 (en) 2020-12-16 2024-04-04 Molecular Partners Ag Novel slow-release prodrugs
TW202300644A (zh) 2021-02-24 2023-01-01 中國大陸商杭州啟函生物科技有限公司 免疫細胞中的嵌合抗原受體
US20240317852A1 (en) 2021-03-09 2024-09-26 Molecular Partners Ag Novel darpin based cd33 engagers
CA3211368A1 (en) 2021-03-09 2022-09-15 Molecular Partners Ag Novel darpin based cd123 engagers
EP4305063A1 (en) 2021-03-09 2024-01-17 Molecular Partners AG Protease cleavable prodrugs
KR20230169182A (ko) 2021-04-09 2023-12-15 몰리큘라 파트너스 아게 신규한 DARPin 기반 CD70 인게이저
WO2023110983A1 (en) 2021-12-14 2023-06-22 Molecular Partners Ag Designed repeat domains with dual binding specificity and their use

Similar Documents

Publication Publication Date Title
JP2023506765A5 (cg-RX-API-DMAC7.html)
JP2022105138A5 (cg-RX-API-DMAC7.html)
JP2010516290A5 (cg-RX-API-DMAC7.html)
JP2008536483A5 (cg-RX-API-DMAC7.html)
JP2019531093A5 (cg-RX-API-DMAC7.html)
JP2010534486A5 (cg-RX-API-DMAC7.html)
JP2001514858A5 (cg-RX-API-DMAC7.html)
JP2014519852A5 (cg-RX-API-DMAC7.html)
JP2023528207A5 (cg-RX-API-DMAC7.html)
JP2023538422A5 (cg-RX-API-DMAC7.html)
JP2013513377A5 (cg-RX-API-DMAC7.html)
RU2014149681A (ru) Антитела с множественной специфичностью
JP2023554379A5 (cg-RX-API-DMAC7.html)
JP2024513559A5 (cg-RX-API-DMAC7.html)
JP2006502702A5 (cg-RX-API-DMAC7.html)
JP2024535925A5 (cg-RX-API-DMAC7.html)
JP2024508969A5 (cg-RX-API-DMAC7.html)
JP2024023268A5 (cg-RX-API-DMAC7.html)
JP2006523448A5 (cg-RX-API-DMAC7.html)
RU2013111675A (ru) Рекомбинантный fc-гибридный белок пятого домена фибронектина типа iii dcc
WO2013134249A1 (en) Adipose tissue targeted peptides
JP2023550287A5 (cg-RX-API-DMAC7.html)
CN103755810A (zh) 一种长效hiv‐1膜融合抑制剂
CA2485587A1 (en) Muteins of placental growth factor type 1, preparation method and application thereof
JP2009507474A5 (cg-RX-API-DMAC7.html)